Buquet-Fagot C - Search Results

1

Sodium butyrate induces G2 arrest in the human breast cancer cells MDA-MB-231 and renders them competent for DNA rereplication.

Lallemand F, Courilleau D, Buquet-Fagot C, Atfi A, Montagne MN, Mester J. Lallemand F, et al. Among authors: buquet fagot c. Exp Cell Res. 1999 Mar 15;247(2):432-40. doi: 10.1006/excr.1998.4370. Exp Cell Res. 1999. PMID: 10066371

2

Antiproliferative effects of sodium butyrate in adriamycin-sensitive and -resistant human cancer cell lines.

Fagot D, Buquet-Fagot C, Lallemand F, Mester J. Fagot D, et al. Among authors: buquet fagot c. Anticancer Drugs. 1994 Oct;5(5):548-56. doi: 10.1097/00001813-199410000-00006. Anticancer Drugs. 1994. PMID: 7858287

3

Sodium butyrate inhibits the phosphorylation of the retinoblastoma gene product in mouse fibroblasts by a transcription-dependent mechanism.

Buquet-Fagot C, Lallemand F, Charollais RH, Mester J. Buquet-Fagot C, et al. J Cell Physiol. 1996 Mar;166(3):631-6. doi: 10.1002/(SICI)1097-4652(199603)166:3<631::AID-JCP18>3.0.CO;2-9. J Cell Physiol. 1996. PMID: 8600167

4

Effects of olomoucine, a selective inhibitor of cyclin-dependent kinases, on cell cycle progression in human cancer cell lines.

Buquet-Fagot C, Lallemand F, Montagne MN, Mester J. Buquet-Fagot C, et al. Anticancer Drugs. 1997 Jul;8(6):623-31. doi: 10.1097/00001813-199707000-00011. Anticancer Drugs. 1997. PMID: 9300578

5

Antimitogenic effects of dexamethasone in chemically transformed mouse fibroblasts.

Fagot D, Buquet-Fagot C, Mester J. Fagot D, et al. Among authors: buquet fagot c. Endocrinology. 1991 Aug;129(2):1033-41. doi: 10.1210/endo-129-2-1033. Endocrinology. 1991. PMID: 1906802

6

Cell cycle dependent regulation of cdc2 mRNA in mouse fibroblasts: requirement of protein synthesis and of continued mitogenic stimulation.

Buquet-Fagot C, Fagot D, Mester J. Buquet-Fagot C, et al. J Cell Physiol. 1993 Apr;155(1):204-9. doi: 10.1002/jcp.1041550126. J Cell Physiol. 1993. PMID: 7682222

7

Mitogenic signaling by prostaglandins in chemically transformed mouse fibroblasts: comparison with phorbol esters and insulin.

Fagot D, Buquet-Fagot C, Mester J. Fagot D, et al. Among authors: buquet fagot c. Endocrinology. 1993 Apr;132(4):1729-34. doi: 10.1210/endo.132.4.8462473. Endocrinology. 1993. PMID: 8462473

8

Synergy between the non-classical thymidylate synthase inhibitor AG337 (Thymitaq) and cisplatin in human colon and ovarian cancer cells.

Raymond E, Djelloul S, Buquet-Fagot C, Mester J, Gespach C. Raymond E, et al. Among authors: buquet fagot c. Anticancer Drugs. 1996 Sep;7(7):752-7. doi: 10.1097/00001813-199609000-00006. Anticancer Drugs. 1996. PMID: 8949986

9

Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast and ovarian cancers.

Raymond E, Buquet-Fagot C, Djelloul S, Mester J, Cvitkovic E, Allain P, Louvet C, Gespach C. Raymond E, et al. Among authors: buquet fagot c. Anticancer Drugs. 1997 Oct;8(9):876-85. doi: 10.1097/00001813-199710000-00009. Anticancer Drugs. 1997. PMID: 9402315

10

Cellular effects of olomoucine, an inhibitor of cyclin-dependent kinases.

Abraham RT, Acquarone M, Andersen A, Asensi A, Bellé R, Berger F, Bergounioux C, Brunn G, Buquet-Fagot C, Fagot D, et al. Abraham RT, et al. Among authors: buquet fagot c. Biol Cell. 1995;83(2-3):105-20. doi: 10.1016/0248-4900(96)81298-6. Biol Cell. 1995. PMID: 7549905

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters